Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04985032 · ClinicalTrials.gov registry record
Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)
A clinical trial of Ductal Carcinoma In Situ and Invasive Ductal Carcinoma of Female Breast, sponsored by RPCR.
- Recruiting
- Registry status
- 200
- Enrollment target
- 2
- Study locations
NCT04985032 is a study of Ductal Carcinoma In Situ and Invasive Ductal Carcinoma of Female Breast that is actively recruiting participants, run by RPCR. The registered enrollment target is 200 participants, below the 244-participant average among 15 other Ductal Carcinoma In Situ trials with a reported enrollment target (18% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04985032, a study of Ductal Carcinoma In Situ and Invasive Ductal Carcinoma of Female Breast, is actively recruiting participants, sponsored by RPCR.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a multi-institutional, prospective, observational registry investigating the safety and efficacy of Accelerated Partial Breast Irradiation (APBI) using a Stereotactic Body Radiation Therapy (SBRT) delivery technique that incorporates real-time image guidance, noncoplanar fields, and respiratory tracking. The study will accrue 200 patients who will be treated to a dose of 30 Gy over the course of 5 fractions. These subjects will then have a follow up time of 5 years
Conditions Studied
Interventions
- RADIATION stereotactic body radiation therapy
Study Locations (2)
Florida
- CyberKnife Center of South Florida in Stuart - Stuart
- CyberKnife Centers of Tampa Bay - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-08-15 |
| Est. Completion | 2027-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04985032
The ClinicalTrials.gov registry entry for NCT04985032 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 244-participant average among 15 other Ductal Carcinoma In Situ trials with a reported enrollment target (18% lower). The listed sponsor is RPCR, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Ductal Carcinoma In Situ appearing as the primary indexed condition, and to 1 intervention - of which stereotactic body radiation therapy is the first listed.
NCT04985032 reports 2 study locations spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04985032 about?
NCT04985032 is a clinical study titled "Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)". This is a multi-institutional, prospective, observational registry investigating the safety and efficacy of Accelerated Partial Breast Irradiation (APBI) using a Stereotactic Body Radiation Therapy (SBRT) delivery technique that incorporates real-time image guidance, noncoplanar fields, and respirat...
What is the current status of trial NCT04985032?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2022-08-15. Estimated completion is 2027-06.
What conditions does trial NCT04985032 study?
This clinical trial studies the following conditions: Ductal Carcinoma In Situ, Invasive Ductal Carcinoma of Female Breast.
What interventions are being tested in trial NCT04985032?
The interventions under investigation include: stereotactic body radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT04985032?
This trial is sponsored by RPCR, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04985032 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ductal Carcinoma In Situ
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
RECRUITING
-
Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ
RECRUITING · NA
-
A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
RECRUITING · NA
-
Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions
RECRUITING · NA
-
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
RECRUITING · Phase 2
-
Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
RECRUITING · Phase 2
Explore more on PlainTrial
Ductal Carcinoma In Situ
All registered trials for this condition
Invasive Ductal Carcinoma of Female Breast
All registered trials for this condition
Florida
All trials with a study site in Florida
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.